New model finds HIV acute phase infectivity may be lower than previously estimated

March 17, 2015

Previous calculations may have overestimated the importance of HIV transmission from recently infected individuals ("acute phase infectivity") in driving HIV epidemics, according to an article published by Steve Bellan of The University of Texas at Austin, and colleagues in this week's PLOS Medicine.

The lower estimates of acute phase infectivity suggest that recently infected individuals--who have not had the chance to start antiretroviral treatment--although still more infectious on average than those in the chronic stage of infection, are not as likely to infect others as was previously thought. Transmission from individuals in the acute phase of HIV infection could therefore pose less of a threat to effectiveness of Treatment as Prevention programs, while programs aimed at early identification of HIV infection could have less of a population-level impact, than previously thought.

The authors used two approaches to estimate acute phase infectivity. The first approach used viral load trajectories and the known relationship between viral load and infectivity to estimate that additional risk of transmission during the acute phase was equivalent to 5.6 extra months of chronic-phase infectivity (5.6 excess hazard months or EHMacute). The second approach used a mathematical model to simulate HIV infection and transmission among couples in the principal prior study that directly measured acute phase infectivity, a cohort study from Rakai, Uganda. This simulation estimated EHMacute to be 8.4. Both approaches yielded EHMacute estimates well below the two most cited previous estimates of acute phase infectivity (EHMacute 31 and 141). Bellan and colleagues determined that the higher estimates in previous studies were mainly the result of unaccounted-for heterogeneity in risk among study couples, and bias due to the exclusion of serodiscordant couples who were lost to follow-up. The authors caution that, even in their updated estimates, the small number of couples in this study result in wide confidence intervals.

The authors say: "Our findings cautiously suggest that the population-level benefits [of ART] might be larger than predicted by earlier estimates."

In an accompanying Perspective on this Research Article, Laith Abu-Raddad of Weill Cornell Medical College, Qatar highlights the importance of understanding how large a role acute HIV infection plays in driving HIV transmission and the value of simulation studies for assessing bias in epidemiologic study design. He cautions that these estimates may not translate to key populations outside of the hyper-epidemics of Africa (such as men who have sex with men, people who inject drugs, female sex workers and their clients). However, he says: "Bellan and colleagues' study has shaken our faith in a result taken for granted for a decade."
-end-
Research Article

Funding: The 2013 International Clinics on Infectious Disease Dynamics and Data, where this work was initiated, was funded by National Institute of Health award R25GM102149, the African Institute for Mathematical Sciences, and the South African Centre for Excellence in Epidemiological Modelling and Analysis. This work was supported by a J.S. McDonnell Foundation grant to JD and National Institute of General Medical Sciences Model of Infectious Disease Agent Study grant U01GM087719 to LAM and APG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The authors have declared that no competing interests exist.

Citation: Bellan SE, Dushoff J, Galvani AP, Meyers LA (2015) Reassessment of HIV-1 Acute Phase Infectivity: Accounting for Heterogeneity and Study Design with Simulated Cohorts. PLoS Med 12(3): e1001801. doi:10.1371/journal.pmed.1001801

Author Affiliations:
The University of Texas at Austin, UNITED STATES
McMaster University, CANADA
Yale School of Public Health, Yale University, UNITED STATES
Yale University, UNITED STATES
The Santa Fe Institute, UNITED STATES

Contact:
Steve Bellan
University of Texas at Austin
+1 (626) 201-4307
steve.bellan@gmail.com

Perspective Article

Funding: This publication was made possible by NPRP 5-752-3-177 from the Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the author. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The author has declared that no competing interests exist.

Citation: Abu-Raddad LJ (2015) Role of Acute HIV Infection in Driving HIV Transmission: Implications for HIV Treatment as Prevention. PLoS Med 12(3): e1001803. doi:10.1371/journal.pmed.1001803

Author Affiliations:
Weill Cornell Medical College in Qatar, Cornell University, QATAR
Weill Cornell Medical College, Cornell University, UNITED STATES
Fred Hutchinson Cancer Research Center, UNITED STATES

PLOS

Related HIV Infection Articles from Brightsurf:

Scientists pinpoint new mechanism that impacts HIV infection
A team of scientists led by Texas Biomed's Assistant Professor Smita Kulkarni, Ph.D. and Mary Carrington, Ph.D., at the Frederick National Laboratory for Cancer Research, published results of a study that pinpointed a long noncoding RNA molecule which influences a key receptor involved in HIV infection and progression of the disease.

HIV: Reprogramming cells to control infection
Following research on cohorts, scientists from the Institut Pasteur have described the characteristics of CD8 immune cells in these 'HIV controller' subjects.

USPSTF recommendation on screening for HIV infection
The US Preventive Services Task Force (USPSTF) recommends screening for HIV infection in adolescents and adults ages 15 to 65; in those younger or older at increased risk of infection; and in all pregnant people.

HIV/tuberculosis co-infection: Tunneling towards better diagnosis
1.2 million people in the world are co-infected by the bacteria which causes tuberculosis and AIDS.

HIV vaccine protects non-human primates from infection
New research shows that an experimental HIV vaccine strategy works in non-human primates.

New guidelines for treatment and prevention of HIV infection in adults
Experts have updated recommendations for the use of antiretroviral drugs in the treatment and prevention of HIV infection.

Updated recommendations for treating, preventing HIV infection
A volunteer panel of experts in HIV research and patient care evaluated new data and treatments to update recommendations from the International Antiviral Society-USA for the use of antiretroviral drugs in this special communication article.

Tracking down T cell targets to tamp down HIV infection
Scientists have narrowed in on a group of gut-residing immune cells that might predispose women to increased HIV infection risk and more severe disease.

Two antibodies are better than one for preventing HIV infection
A cocktail of two broadly-neutralizing HIV-1 antibodies (bNAbs) protected primates against infection with a mixed population of HIV viruses -- conditions that mimic real-world transmission -- researchers report.

Novel approach to track HIV infection
Scientists used a novel live-cell fluorescent imaging system that allowed them for the first time to identify individual viral particles associated with HIV infection.

Read More: HIV Infection News and HIV Infection Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.